ロード中...
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...
保存先:
主要な著者: | , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
MDPI AG
2020-06-01
|
シリーズ: | International Journal of Molecular Sciences |
主題: | |
オンライン・アクセス: | https://www.mdpi.com/1422-0067/21/12/4544 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|